An Analysis of Organogenesis Holdings Inc (ORGO)’s Potential Price Growth

Organogenesis Holdings Inc’s filing revealed that its 10% Owner ERANI ALBERT unloaded Company’s shares for reported $76875.0 on Jan 10 ’24. In the deal valued at $4.28 per share,17,972 shares were sold. As a result of this transaction, ERANI ALBERT now holds 59,007,134 shares worth roughly $154.01 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, ERANI ALBERT sold 17,972 shares, generating $76,875 in total proceeds. Upon selling the shares at $4.28, the 10% Owner now owns 59,007,134 shares.

Before that, ERANI ALBERT sold 197,921 shares. Organogenesis Holdings Inc shares valued at $863,985 were divested by the 10% Owner at a price of $4.37 per share. As a result of the transaction, ERANI ALBERT now holds 59,025,106 shares, worth roughly $154.06 million.

Cantor Fitzgerald initiated its Organogenesis Holdings Inc [ORGO] rating to an Overweight in a research note published on February 07, 2024; the price target was $5. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in mid June with a ‘”an Equal-weight”‘ rating. BTIG Research also remained covering ORGO and has increased its forecast on May 24, 2023 with a “Buy” recommendation from previously “Neutral” rating. BTIG Research revised its rating on November 10, 2022. It rated ORGO as “a Neutral” which previously was an “a Buy”.

Price Performance Review of ORGO

On Tuesday, Organogenesis Holdings Inc [NASDAQ:ORGO] saw its stock fall -6.79% to $2.61. Over the last five days, the stock has lost -0.38%. Organogenesis Holdings Inc shares have fallen nearly -36.19% since the year began. Nevertheless, the stocks have risen 27.94% over the past one year. While a 52-week high of $4.70 was reached on 01/08/24, a 52-week low of $1.79 was recorded on 03/01/24. SMA at 50 days reached $3.22, while 200 days put it at $3.14. A total of 0.75 million shares were traded, compared to the trading of 0.25 million shares in the previous session.

Levels Of Support And Resistance For ORGO Stock

The 24-hour chart illustrates a support level at 2.49, which if violated will result in even more drops to 2.36. On the upside, there is a resistance level at 2.79. A further resistance level may holdings at 2.96. The Relative Strength Index (RSI) on the 14-day chart is 36.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.14%. Stochastics %K at 38.41% indicates the stock is a holding.

How much short interest is there in Organogenesis Holdings Inc?

A steep rise in short interest was recorded in Organogenesis Holdings Inc stocks on Mar 15, 2024, growing by 0.54 million shares to a total of 8.01 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 7.47 million shares. There was a rise of 6.74%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 26.30% of the overall stock float, the days-to-cover ratio (short ratio) rose to 10.47.

Most Popular